MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

Amcol Health & Beauty Solutions introduces new revolutionary skin-brightening cream

Release issued 18th August 2008

ARLINGTON HEIGHTS, IL (August 18, 2008) - AMCOL HBS, a recognized leader in skin care technology and dermatology products, has introduced Skin Brightening Complex, a hydroquinone-free skin rejuvenation therapy developed to return health and radiance to mature skin. The product is built on AMCOL HBS' proprietary MICROSPONGE® delivery system technology (www.microsponge.com).

This advanced skin-care formulation has been clinically proven to substantially brighten skin and reduce the appearance of discolorations due to photodamage, pregnancy, acne and environmental factors. Milder than traditional bleaching creams, and more affordable than expensive medical laser treatments, HBS Skin Brightening Complex fills a significant market gap in treatment options for hyperpigmentation.

"AMCOL HBS is dedicated to providing the best possible solutions for our customers. With our unique technologies and formulation and manufacturing expertise, we are uniquely positioned to partner with our customers, whether they need specialty ingredients, custom formulations or turnkey finished products," says Kevin Cureton, HBS Managing Director. "HBS Skin Brightening Complex represents a notable achievement in skin rejuvenation, and a sophisticated addition to the AMCOL HBS product line."

HBS Skin Brightening Complex is a dual-action therapy combining the skin-brightening effectiveness of kojic dipalmitate with the rejuvenating benefits of retinol to combat the age spots and fine lines that often accompany aging. HBS Skin Brightening Complex evens out skin tone and reduces discoloration, resulting in a complexion that is luminous and more youthful in appearance. In a 13-week clinical trial, trained clinicians and participants alike saw substantial improvement under visible, UVA and polarized light.

"Hydroquinone is considered the gold standard for skin lightening, and therefore it was very impressive when our clinical studies showed similar skin-lightening performance for our product in comparison to the leading market 2% hydroquinone cream," says Ralph Spindler, Director of Research & Development.

The actual application and esthetics of the HBS Skin Brightening Complex are equally impressive.

"This product works really well and, unlike other retinol products, does not irritate my skin. I would recommend it for all skin types." says a Princeton, N.J., salon-based esthetician. "It feels fluid and silky, absorbs quickly and dries to a nice matte finish."

Because the formulation is based on MICROSPONGE technology, HBS Skin Brightening Complex maintains its effectiveness over time, unlike many other retinol products. Additionally, the MICROSPONGE sustained-release process improves performance without compromising mildness, even on sensitive skin.

Skin Brightening Complex, available exclusively from AMCOL HBS, is a clinically proven effective alternative to traditional skin lightening products, restoring health and radiance to dull and uneven skin safely, effectively and gently.

About AMCOL HBS
AMCOL Health & Beauty Solutions, Inc. (HBS) is a wholly owned subsidiary of AMCOL International Corporation, a $750 million specialty materials producer and marketer. HBS was incorporated in 2001 to apply AMCOL's 75 years of polymer and mineral technology expertise to the Personal Care, Cosmetics, Pharmaceutical, and Nutraceutical markets. Through its leading technology platforms, formulation and manufacturing expertise and clinically proven products, HBS is able to help its customers achieve greater success and profitability.

Study conducted by Springhouse Skin Research Inc.; Michael Christensen, Ph. D., investigator. For more information on study protocol or findings, please contact Courtney Keppelman.

Company details

If you want to find out more about the company visit AMCOL Health & Beauty Solutions, Inc profile.

Latest AMCOL Health & Beauty Solutions, Inc press releases

More Press Releases

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us